Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 16, 2023 | Xingji Meizu | $275.9M Series A | Asia Investment Capital | QC Capital |
| Aug 11, 2023 | Neurophth Therapeutics | $95.0M Series C | Hubei KTLC, Wuhan, Wuhan Hi-Tech Holding Group, Wuhan Optical Valley Financial Holding Group, Yangtze River-CMB International Industry Fund | CMG-SDIC Capital, Silicon Paradise Asset Management, Yangtze River Industry Fund |